Lujun Chen

Efficacy and safety of bispecific antibodies vs. immune checkpoint blockade combination therapy in cancer: a real-world comparison

Zhuojun Zheng, Xiaoshu Zheng, Yuan Shi, 2024, Molecular cancer.

Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues

Liangrong Shi, Xiao Zheng, Xuemin Chen, 2024, Cancer control : journal of the Moffitt Cancer Center.

Association of CD8+TILs co-expressing granzyme A and interferon-γ with colon cancer cells in the tumor microenvironment

Shaoxian Wu, M. Yuan, Zhang Fang, 2024, BMC cancer.

Unlocking the potential of HHLA2: identifying functional immune infiltrating cells in the tumor microenvironment and predicting clinical outcomes in laryngeal squamous cell carcinoma

Haixiang Xue, Junjun Chen, Lujun Chen, 2024, Cancer immunology, immunotherapy : CII.

NUP37 promotes the proliferation and invasion of glioma cells through DNMT1-mediated methylation

Shaoxian Wu, Junjun Chen, Lujun Chen, 2024, Cell death discovery.

XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial

Li Zhou, D. Zhang, Q. Pan, 2024, Signal transduction and targeted therapy.